Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evommune (EVMN) Preferred Shares (2024)

Evommune (EVMN) has disclosed Preferred Shares for 1 consecutive years, with $8.9 million as the latest value for Q4 2024.

  • Quarterly Preferred Shares changed N/A to $8.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Dec 2024, changed N/A year-over-year, with the annual reading at $8.9 million for FY2024, N/A changed from the prior year.
  • Preferred Shares for Q4 2024 was $8.9 million at Evommune.
  • The five-year high for Preferred Shares was $8.9 million in Q4 2024, with the low at $8.9 million in Q4 2024.